Durable therapeutic gain despite competing mortality in long-term follow-up of a randomized hyperfractionated radiotherapy trial for locally advanced head and neck cancer
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Translational Radiation Oncology"
DOI: 10.1016/j.ctro.2020.01.003
Abstract: Highlights • Hyperfractionated RT with augmented dose provides durable enhanced disease control.• Late toxicity is unchanged with higher optimal doses using smaller fraction sizes.• Hyperfractionation improves overall survival but mortality profile evolves over time.• Altered… read more here.
Keywords: competing mortality; durable therapeutic; mortality; despite competing ... See more keywords